The price of this domestically produced innovative drug for atopic dermatitis has dropped from 980 yuan to 360 yuan, a decrease of 63%.

In order to improve the accessibility of medication for patients with atopic dermatitis, Shanghai Zedman Medical Technology Co., Ltd. recently announced that the retail price of its self-developed innovative drug Bonviv Mode cream has been adjusted from 980 yuan per tube to 360 yuan per tube, a decrease of 63%. This price reduction action, which took effect on July 21st, has quickly sparked positive market feedback. As of now, with various platforms gradually replenishing stocks, the previously tight supply situation has been alleviated. Experts remind patients to purchase medication through legitimate channels, to stock up on medication rationally, to avoid hoarding, and to follow medical advice or guidance from professional pharmacists when using medication.